Previous Article | Next Article 
Molecular and Cellular Biology, June 1999, p. 4079-4092, Vol. 19, No. 6
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Separation and Characterization of the Activated
Pool of Colony-Stimulating Factor 1 Receptor Forming Distinct
Multimeric Complexes with Signalling Molecules in
Macrophages
V.
Kanagasundaram,*
A.
Jaworowski,
R.
Byrne, and
J. A.
Hamilton
Department of Medicine, University of
Melbourne, Royal Melbourne Hospital, Parkville, Victoria 3050, Australia
Received 11 August 1998/Returned for modification 6 October
1998/Accepted 3 March 1999
 |
ABSTRACT |
Colony-stimulating factor 1 (CSF-1) triggers the activation of
intracellular proteins in macrophages through selective assembly of
signalling complexes. The separation of multimeric complexes of the
CSF-1 receptor (CSF-1R) by anion-exchange chromatography enabled the
enrichment of low-stoichiometry complexes. A significant proportion of
the receptor in CSF-1-stimulated cells that neither possessed
detectable tyrosine kinase activity nor formed complexes was separated
from the receptor pool displaying autokinase activity that formed
chromatographically distinct multimeric complexes. A small pool of
CSF-1R formed a multimeric complex with phosphatidylinositol-3 kinase
(PI-3 kinase), SHP-1, Grb2, Shc, c-Src, Cbl, and a significant number
of tyrosine-phosphorylated proteins in CSF-1-stimulated cells. The
complex showed a considerable amount of CSF-1R complex-associated kinase activity. A detectable level of the complex was also present in
untreated cells. PI-3 kinase in the multimeric complex displayed low
lipid kinase activity despite the association with several proteins.
The major pool of activated CSF-1R formed transient multimeric
complexes with distinctly different tyrosine-phosphorylated proteins,
which included STAT3 but also PI-3 kinase, Shc, SHP-1, and Grb2. A
significant level of lipid kinase activity was detected in PI-3 kinase
in the latter complexes. The different specific enzyme activities of
PI-3 kinase in these complexes support the notion that the activity of
PI-3 kinase is modulated by its association with CSF-1R and other
associated cellular proteins. Specific structural proteins associated
with the separate CSF-1R multimeric complexes upon CSF-1 stimulation
and the presence of the distinct pools of the CSF-1R were dependent on
the integrity of the microtubular network.
 |
INTRODUCTION |
Macrophage colony-stimulating factor
1 (CSF-1) is a lineage-specific growth factor required for the
survival, proliferation, and differentiation of mononuclear phagocytes
(51). The biological effects of CSF-1 are mediated through a
single class of high-affinity CSF-1 receptor (CSF-1R) encoded by the
c-fms proto-oncogene (48). The mature
glycosylated form of the CSF-1R, expressed as a 165-kDa transmembrane
glycoprotein, has a structural domain arrangement characteristic of a
family of tyrosine kinase receptors, members of which include
platelet-derived growth factor receptor (PDGFR), c-Kit, and Flt3/FLK3
receptor (43).
In the absence of CSF-1, the CSF-1R is present in an aggregated or a
dynamic interactive state (27). CSF-1 binding results in a
conformational change to the receptor subunits which causes the
clustered CSF-1 receptors to form noncovalent dimers, thus activating
the receptor tyrosine kinase (27). The activation initiates
a cascade of signalling events leading to the transient phosphorylation
of primarily cytosolic proteins (47). In parallel with these
events, the activated ligand-bound receptor is rapidly lost from the
cell surface as a consequence of internalization via clathrin-coated
pits (31) before being degraded in a chloroquine-sensitive lysosomal compartment (15). Although the ligand and receptor initially share the same endocytic pathway, our recent study suggests that they may be targeted to separate compartments at later stages of
degradation in some populations of macrophages (23). The receptor is downmodulated following dephosphorylation and
internalization, but the importance of these events in attenuating the
biological signal remains unclear (27).
The activation of the CSF-1R upon ligand binding leads to the
transphosphorylation of specific tyrosine residues in the cytoplasmic domain of the receptor, and their requirement for CSF-1 signal transduction has been investigated by mutagenesis (6, 45, 54). The sites that have been mapped include Tyr697, Tyr706, and
Tyr721 in the kinase insert domain of the murine CSF-1R and Tyr807 in
the kinase domain. Many of these tyrosine phosphorylation sites serve
as binding sites for Src homology 2 (SH2)-containing proteins that
relay and amplify the signal from the receptor to the nucleus along
specific intracellular signalling pathways (13, 52). Tyr559
in the juxtamembrane domain of the receptor is a binding site for Src
family members (2). The adapter protein Grb2 associates with
Tyr697, which enables the nucleotide exchange factor Sos1,
constitutively bound to Grb2, to activate Ras (28, 54).
Tyr706 was identified as a site required for the activation of the
STAT1 transcription factor (34), while Tyr721 regulates the
CSF-1-induced activity of phosphatidylinositol-3 kinase (PI-3 kinase)
through the binding of the regulatory p85 subunit of PI-3 kinase
(40).
CSF-1 induces responses in macrophages ranging from early morphological
changes, which include membrane ruffling, filopodium formation, cell
spreading, and cytoskeletal reorganization, to more long-term effects
associated with survival, proliferation, and differentiation of the
cell (5). The biological effects elicited by the growth
factor are regulated by signalling pathways. The stimulation of such
pathways triggers the phosphorylation and activation of intracellular
proteins which selectively assemble into signalling complexes. The
localization of these complexes in the cell has been found to be
essential to signal transmission by an extracellular stimulus
(37). CSF-1R expressed in primary bone marrow-derived
macrophages or CSF-1-dependent macrophage cell lines has not been found
to associate with many signalling proteins in stoichiometric amounts on
ligand activation (7, 24, 28). The discovery of new
potential binding partners for CSF-1R by the sensitive yeast two-hybrid
technique (7) and the recent demonstration of a transient
association between the tyrosine phosphatase SHP-1, p130
tyrosine-phosphorylated protein, BIT, and the CSF-1R in
CSF-1-stimulated macrophages (53) emphasize not only the
existence of yet-to-be discovered binding proteins but also the need to
progress to methods that allow for more sensitive detection of
transient complexes. Given our previous observation that a complex
formed between CSF-1R, PI-3 kinase, and several tyrosine-phosphorylated proteins in CSF-1-treated macrophages is
stable to anion-exchange chromatography (24), we
fractionated cell lysate by anion-exchange chromatography to enrich for
other CSF-1R complexes present in small amounts in the cell. We report the separation of chromatographically stable multimeric complexes of
CSF-1R with distinct tyrosine-phosphorylated proteins, some of which
have been identified to be signalling molecules previously not shown to
form a complex with the activated CSF-1R. The study also examines the
different pools of two of the signalling molecules, PI-3 kinase and
SHP-1, in detail and their interaction with other tyrosine-phosphorylated proteins, in particular their association with
chromatographically separate pools of the activated CSF-1R. The
characterization of the various pools of signalling molecules may
provide further understanding of the regulation of activity of the
signalling proteins through specific assembly of complexes.
 |
MATERIALS AND METHODS |
Reagents.
The following antibodies were obtained from
commercial sources: monoclonal antiphosphotyrosine antibody 4G10
(anti-pTyr) conjugated to horseradish peroxidase (HRP), rabbit
polyclonal antibody against the p85
subunit of PI-3 kinase
(anti-p85
), and rabbit polyclonal antibody against SHP-1 (Upstate
Biotechnology, Lake Placid, N.Y.); rabbit polyclonal antibodies
anti-Cbl, anti-Shc, and anti-c-Src and goat polyclonal antibody
anti-PI-3 kinase p110
(Santa Cruz Biotechnology, Santa Cruz,
Calif.); monoclonal antibodies antidynamin and anti-Grb2 as well as
polyclonal antibodies anti-STAT3 and anti-TYK2 (Transduction
Laboratories); and mouse anticlathrin (ICN Biochemicals Inc., Costa
Mesa, Calif.). Polyclonal anti-CSF-1R antibody, used for
immunoprecipitations, was raised in our laboratory as described
previously (24). A second polyclonal antibody to the kinase
domain of the murine CSF-1R (28), used for immunoblotting membranes, was a gift from L. Rohrschneider (Fred Hutchinson Cancer Research Center, Seattle, Wash.). The reagents cytochalasin D and
nocodazole were purchased from ICN Biochemicals (Aurora, Ohio) and
Sigma, respectively. Purified human recombinant CSF-1 and PDGF were
gifts from Chiron, Emeryville, Calif., and Amgen Pharmaceuticals, Boulder, Colo., respectively.
Cell culture conditions.
The CSF-1-dependent murine
macrophage cell line BAC1.2F5 was grown in 15-cm-diameter tissue
culture plates as described previously (24). The cells were
seeded at a density of 105 cells/ml and cultured until
subconfluent. BAC1.2F5 cells were rendered quiescent by reculturing
them in growth medium lacking L-cell-conditioned medium for 18 to
20 h prior to stimulation with CSF-1 at 5,000 U/ml at 37°C for
the times indicated in Results. Experiments involving depolymerizing
agents were carried out by pretreating BAC1.2F5 cells with nocodazole
(40 µg/ml) or cytochalasin D (2.5 µM) for 60 min at 37°C prior to
stimulation with growth factor.
Immunoprecipitations.
Untreated or CSF-1-treated BAC1.2F5
cells were placed on ice and washed twice in ice-cold
phosphate-buffered saline prior to solubilization in lysis buffer
containing 25 mM Tris-Cl (pH 7.5), 137 mM NaCl, 1 mM EDTA, 1% Triton
X-100, 10 µg of aprotinin per ml, 1 µM leupeptin, 1 µM pepstatin,
0.1 mM pefabloc, 50 mM sodium fluoride, 50 mM
-glycerophosphate, and
1 mM sodium vanadate at 4°C. Extract containing 2 mg of protein was
precleared before immunoprecipitation with specific antibodies
overnight at 4°C followed by incubation with protein A-Sepharose for
a further 1 h. Immunoprecipitated proteins were resolved on a
sodium dodecyl sulfate (SDS)-10% polyacrylamide gel and transferred
to a nitrocellulose membrane for immunoblotting. Proteins recognized by
the primary antibody were visualized with HRP-conjugated secondary
antibodies and enhanced chemiluminescence reagents (Amersham Corp.).
Blots were reprobed with other primary antibodies after removal of
bound antibody by incubation in 62.5 mM Tris-Cl (pH 6.7)-0.1 M
2-mercaptoethanol-2% SDS (60°C, 30 min).
Column chromatography.
Untreated or CSF-1-treated (2 or 30 min at 37°C) BAC1.2F5 cells were lysed in solubilization buffer as
described above. Subsequent steps, including the column chromatography,
were carried out at 4°C. Approximately 3 mg of total protein extract
was dialyzed against 100 ml of buffer A (10 mM Tris-Cl [pH 7.5], 40 mM
-glycerophosphate, 1 mM dithiothreitol, 1 mM EGTA, 0.1 mM sodium
vanadate). The extract was then centrifuged at 15,000 × g for 5 min to remove unsolubilized material and loaded onto a
1-ml MonoQ anion-exchange Econo column (Bio-Rad) equilibrated in buffer
A. The column was washed in 10 volumes of buffer A at a flow rate of 1 ml/min. The unadsorbed fractions were pooled for analysis. A gradient
of 0 to 400 mM NaCl was then applied, and 1-ml fractions collected over
30 min for analysis. The unadsorbed material and every third fraction collected over the NaCl gradient were analyzed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) followed by immunoblotting with specific
antibodies as indicated in Results. Equal volumes of the unadsorbed
fraction (0.3 ml) and eluted fractions from the salt gradient were
immunoprecipitated with the specific antibodies, and the
immunoprecipitates were analyzed by immunoblotting the membrane with
specific antibodies.
In vitro kinase activity.
Equal volumes (0.3 ml) of
fractions following the separation of BAC1.2F5 lysates on the MonoQ
anion-exchange column were immunoprecipitated with anti-CSF-1R and
assayed for in vitro CSF-1R kinase activity. The kinase assay was
carried out by resuspending the protein A-Sepharose in 20 µl of
kinase buffer (25 mM HEPES [pH 7.5], 10 mM MnCl2, 0.1 mM
sodium vanadate, 50 mM sodium fluoride, 50 mM
-glycerophosphate, 1 µM leupeptin, 1 µM pepstatin, and 0.1 mM pefabloc) and incubating in the presence of 10 µCi of [
-32P]ATP (4,000 Ci/mmol) at 30°C for 15 min. The reaction was terminated by adding
SDS loading buffer, and the samples were analyzed by separation on
SDS-PAGE. The polyacrylamide gel was incubated in 5 M KOH at 55°C for
60 min in order to remove background contributed by serine
phosphorylation (10). The gel was dried, and results were
analyzed by autoradiography.
PI-3 kinase assay.
Equal volumes (0.4 ml) of the fractions
obtained from chromatographic separation of cell lysate were
immunoprecipitated with anti-p85
, and the immunoprecipitates were
assayed for PI-3 kinase activity in vitro as described previously
(23, 39).
 |
RESULTS |
CSF-1R complexes detected by immunoprecipitation.
CSF-1
stimulation of macrophages has been shown to result in the assembly of
different complexes involving the CSF-1R (19, 24, 28, 54).
However, not all signal transduction complexes formed can be
demonstrated by coimmunoprecipitation studies, especially when
antireceptor antibodies are used for the immunoprecipitation (7,
24, 53). We were unable to detect significant association of
tyrosine-phosphorylated proteins with the CSF-1R in anti-CSF-1R immunoprecipitates of lysates prepared from CSF-1-treated BAC1.2F5 cells (Fig. 1), consistent with
observations made by others (3, 12, 39, 58), and attempts to
increase the sensitivity of the assay by pretreating the macrophages
with iodoacetic acid (IAA) prior to CSF-1 treatment also failed to show
associated tyrosine-phosphorylated proteins (Fig. 1). In agreement with
the earlier work, we did observe an overall increase in the tyrosine phosphorylation of cellular proteins (Fig. 1). This effect has been
shown to be due, at least in part, to inhibition of receptor internalization (27) but may also be a consequence of
inactivation of protein tyrosine phosphatases through
carboxymethylation of the cysteine residue at the active site
(61) by IAA. These observations might suggest that only a
small population of CSF-1R physically associates with intracellular
signalling molecules and therefore the complexes cannot be detected in
CSF-1R immunoprecipitates from crude cell lysate. In the following
experiments, we demonstrated that enrichment of CSF-1R by column
chromatography allows us to detect the presence of multimeric
CSF-1R-containing complexes. Furthermore, association with different
intracellular proteins gives rise to several chromatographically
distinct CSF-1R-containing complexes.

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 1.
Tyrosine-phosphorylated proteins in CSF-1R
immunoprecipitates. Quiescent BAC1.2F5 cells were treated with 8 mM IAA
for 15 min at 37°C where indicated before stimulation with CSF-1 for
2 min at 37°C. Lysates (left panel) or anti-CSF-1R immunoprecipitates
(IP) of the lysates (right panel) were resolved by SDS-PAGE, and
proteins were transferred to nitrocellulose. The immunoblots were
probed with anti-pTyr (4G10)-HRP. The positions of prestained
molecular mass markers are indicated.
|
|
Fractionation of CSF-1R, signalling proteins, and other
tyrosine-phosphorylated proteins from cell lysates on anion-exchange
chromatography.
Solubilized lysates prepared from untreated or
CSF-1-treated BAC1.2F5 cells were applied to an anion-exchange column,
and protein fractions were eluted with an NaCl gradient. The fractions were then analyzed for the presence of CSF-1R. In untreated BAC1.2F5 cell lysate, CSF-1R fractionated into three pools: one pool present in
the unadsorbed fraction, a second distinct pool eluting at approximately 90 mM NaCl (fraction 17 [Fr 17]), and a third pool, containing the majority of the immunoreactivity to CSF-1R, eluting at
330 to 370 mM NaCl (Fr 35 to 38) (Fig.
2A). Fractions eluting beyond Fr 38 did not contain detectable levels of
CSF-1R (data not shown).

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 2.
Distribution of CSF-1R, tyrosine-phosphorylated
proteins, and signalling proteins in untreated and CSF-1-stimulated
lysates following anion-exchange column chromatography. (A) Solubilized
lysate of untreated or CSF-1-treated (2 or 30 min at 37°C) BAC1.2F5
cells was applied to a MonoQ anion-exchange column (Bio-Rad), and
protein fractions were eluted with a 0 to 0.4 M NaCl gradient. Aliquots
of 1-ml fractions and the initial lysate (Lys) were analyzed by
SDS-PAGE, and protein was transferred to nitrocellulose which was
immunoblotted with anti-CSF-1R. The pools containing CSF-1R are
indicated, in order of their elution from the ion-exchange column, as
Uad (unadsorbed), peak I (Fr 17), peak II (Fr 23 to 32; evident on
CSF-1 treatment), and peak III (Fr 35 to 38). (B) The membrane was
reprobed with anti-pTyr (4G10)-HRP. Tyrosine-phosphorylated CSF-1R
(band a) and other tyrosine-phosphorylated proteins (bands b, c, d, e,
and f) enriched in specific fractions are marked. (C) The immunoblots
of fractions from the separation of untreated or 2-min-CSF-1-treated
BAC1.2F5 cell lysates (Lys) were also probed with antibodies to
specific signalling proteins as indicated. The fractionations were
representative of eight experiments.
|
|
Stimulation of the macrophages with CSF-1 (2 min) resulted in a change
in the distribution of CSF-1R from that observed with
untreated cell
lysate. The most significant change was a shift
in the immunoreactivity
of CSF-1R to a broad peak over a range
of NaCl concentrations (170 to
300 mM NaCl) (Fr 23 to 32) (Fig.
2A). For ease of discussion, we have
named the pools containing
CSF-1R, in order of their elution from the
ion-exchange column,
Uad (unadsorbed), peak I (Fr 17), peak II (Fr 23 to 32; evident
only on CSF-1 treatment), and peak III (Fr 35 to 38).
The amount
of detectable CSF-1R in Uad remained relatively unchanged on
CSF-1
stimulation, while the CSF-1R in peak I diminished slightly.
Extension
of the incubation time with CSF-1 to 30 min showed the
distribution
of the fractionated CSF-1R to follow a profile similar to
that
of 2-min-stimulated cell lysate, but the level of CSF-1R
immunoreactivity
was considerably diminished (Fig.
2A), consistent with
the internalization
of a large proportion of the CSF-1R
(
32). The fractionations
demonstrated in Fig.
2A are
representative of eight experiments,
and approximately 90 to 96% of
the CSF-1R loaded onto the column
was recovered following
fractionation. These observations suggest
that the CSF-1R distributes
in particular pools which change with
time following CSF-1 binding.
Peak II was a transient pool which
appeared initially on CSF-1
stimulation but, relative to peak
I, rapidly disappeared on further
stimulation. The decrease in
the level of receptor in peak II
corresponded to the time course
of internalization and degradation of
the CSF-1R (
27); longer
incubation with CSF-1 (4 h) led to
the appearance of a separate
pool of receptor in peak III, similar to
the distribution in untreated
cells (data not
shown).
Having established the profile of fractionation of the CSF-1R, we next
probed the membrane with anti-pTyr to determine the
tyrosine
phosphorylation status of the CSF-1R in the various peaks
and to
monitor the distribution of other proteins that are tyrosine
phosphorylated upon CSF-1 stimulation (Fig.
2B). Again, the
fractionations
were representative of eight experiments, as
mentioned above,
and close to 100% recovery of tyrosine-phosphorylated
proteins
in the initial lysate was achieved following
fractionation. In
unstimulated cells, CSF-1R (p165) in both Uad and
peak I was found
to be tyrosine phosphorylated and presumably
represents the basal
level of phosphorylation of the receptor in
growth-arrested cells
(Fig.
2B). In contrast, the main immunoreactive
pool of CSF-1R
present in peak III (Fig.
2A) showed no detectable
tyrosine phosphorylation
(Fig.
2B). CSF-1 stimulation resulted in a
significant change
in the profile of tyrosine-phosphorylated CSF-1R as
well as in
those of other tyrosine-phosphorylated proteins. Apart from
the
tyrosine-phosphorylated CSF-1R (p165), which was enriched in Fr
23 to 32 (Fig.
2B, band a), specific tyrosine-phosphorylated proteins
were
enriched in particular fractions. For example, p120 (band
b) and p65
(band c) were enriched in Fr 17, p100 (bands d) in
Fr 20 to 23, and p80
(band e) and p44 (band f) in Fr 20 following
the fractionation of
2-min-CSF-1-treated cell lysate (Fig.
2B).
Fr 17 (peak I), with a high
proportion of tyrosine-phosphorylated
proteins, contained only 1% of
the total solubilized protein in
the cell lysate. On the other hand,
60% of the total protein was
present in the Uad fraction, which also
contained a separate pool
of tyrosine-phosphorylated proteins. Most
tyrosine-phosphorylated
proteins observed in the untreated and
CSF-1-stimulated crude
cell lysates were fractionated within the NaCl
gradient used (Fig.
2B). The level of tyrosine phosphorylation of most
of the proteins
fractionated from 30-min-CSF-1-treated cell lysate
decreased significantly
relative to that of 2-min-CSF-1-treated cells
(Fig.
2B), but the
profiles of the distributions of
tyrosine-phosphorylated proteins
fractionated along the gradient did
not differ. The observations
that the extent of the tyrosine
phosphorylation of the proteins
did not always parallel the elution
profile suggests that the
tyrosine phosphorylation status of proteins
alone was not responsible
for the change in the chromatographic
distribution of the CSF-1R
and other proteins following CSF-1
stimulation (see
Discussion).
In order to identify some of the tyrosine-phosphorylated proteins
resolved in Fig.
2B, we next determined the distribution
of signalling
proteins previously shown to be activated or recruited
to the CSF-1R
upon CSF-1 stimulation (Fig.
2C). Approximately
90 to 95% of the
signalling proteins in the initial lysate were
recovered following
fractionation, as also found for the CSF-1R
above, and most of the
detectable immunoreactivity to the signalling
proteins eluted within
the NaCl concentration range shown. Significant
levels of
immunoreactivity to most signalling proteins screened
(STAT3, TYK2,
PI-3 kinase [p85

], Grb2, Shc, and SHP-1) were present
in the Uad
peak on analysis of either untreated or CSF-1-treated
cell lysates
(Fig.
2C). However, differences in the distribution
of proteins along
the NaCl gradient were observed. Proteins involved
in the JAK/STAT
pathway of activated macrophages, namely, STAT3
and TYK2
(
33), showed a significant change in distribution following
CSF-1 stimulation. These proteins coeluted with a significant
proportion of the adsorbed pool of tyrosine-phosphorylated CSF-1R
in
peak II (Fig.
2C). PI-3 kinase, previously reported to be activated
in
ligand-stimulated macrophages (
40), also showed a
significant
change in its distribution on CSF-1 stimulation by
fractionating
over a broad NaCl concentration range (Fr 17 to 32),
which included
peak I and peak II (Fig.
2C). PI-3 kinase detected in
peak I (Fr
17) with Grb2 and Shc (Fig.
2C) was present in both
unstimulated
and CSF-1-stimulated cells. Detectable levels of Cbl, a
molecule
identified to be a negative regulator (
36),
cofractionated with
these proteins in peak I only on CSF-1 stimulation.
It is interesting
that the cofractionation of a pool of
tyrosine-phosphorylated
CSF-1R, PI-3 kinase, Cbl, Shc, and Grb2 in
CSF-1-stimulated macrophages
eluting at 90 mM NaCl was associated with
the formation of a multimeric
complex which is stable to anion-exchange
chromatography (
24).
The low levels of SHP-1 present in
fractions eluted along the
NaCl gradient were evident only on
immunoprecipitation with anti-SHP-1
antibody (see below). Many of the
signalling proteins known to
be activated on CSF-1 stimulation
comigrated with tyrosine-phosphorylated
bands in the adsorbed fractions
(data not shown), reflecting the
degree of enrichment of the activated
or participating pool of
signalling
molecules.
Activated CSF-1R forms chromatographically distinct multimeric
complexes.
Having established first that the chromatographic
distributions of the CSF-1R and signalling proteins change on CSF-1
stimulation and second that distinct pools of tyrosine-phosphorylated
proteins cochromatograph with separate pools of tyrosine-phosphorylated CSF-1R, we next explored the hypothesis that the distribution was
partly a consequence of formation of multimeric complexes containing
CSF-1R. We therefore examined anti-CSF-1R immunoprecipitates of the
column fractions for specific signalling proteins.
For Fig.
3A, anti-CSF-1R
immunoprecipitates of equal volumes of the fractions
containing the CSF-1R (Fig.
2A) were initially
probed for
tyrosine-phosphorylated proteins. We have included
again the
distribution of CSF-1R in these fractions for convenience.
In contrast
to the results in Fig.
1, where tyrosine-phosphorylated
proteins were
not readily detected in anti-CSF-1R immunoprecipitates
of CSF-1-treated
whole-cell lysate, analysis of immunoprecipitates
from the column
fractions of CSF-1-treated cell lysate revealed
the
coimmunoprecipitation of tyrosine-phosphorylated proteins
with the
tyrosine-phosphorylated CSF-1R (Fig.
3A) in selected
fractions (Fr 17 to 32). Hence, an important outcome of the anion-exchange
chromatography has been the considerable enrichment of certain
pools of
receptor forming chromatographically stable multimeric
complexes with
tyrosine-phosphorylated proteins. The Uad pool
of CSF-1R, which was
chromatographically separate from the CSF-1R
pools in the adsorbed
fractions (peak I and peak II), did not
coimmunoprecipitate with
tyrosine-phosphorylated proteins (Fig.
3A) contained in the same
fraction (Fig.
2B).

View larger version (48K):
[in this window]
[in a new window]
|
FIG. 3.
Separation of multimeric complexes of CSF-1R
containing distinct signalling proteins. (A) Fractions following the
separation of untreated or CSF-1-treated (2 min at 37°C) BAC1.2F5
lysate by anion-exchange chromatography that were identified as
containing CSF-1R by immunoblotting (top panel) were immunoprecipitated
with anti-CSF-1R. The immunoprecipitates were resolved by SDS-PAGE and
transferred to nitrocellulose. The membrane was initially probed with
anti-pTyr (4G10)-HRP. The arrows indicate the positions of CSF-1R,
PI-3 kinase p85 , and SHP-1. The pools of fractions identified as
containing CSF-1R are indicated as Uad, peak I (pKI), and peak II. U,
Uad; US, unstimulated. (B) The membrane was then stripped and reprobed
with anti-STAT3, anti-PI-3 kinase p85 , anti-Grb2, anti-Shc, and
anti-SHP-1 as indicated. (C) The CSF-1R immunoprecipitates of fractions
from CSF-1-treated lysate fractionation were also assayed for in vitro
kinase activity with [ -32P]ATP. The proteins were
resolved by SDS-PAGE, and the gel was incubated with 5 M KOH at 55°C
for 30 min. The dried gel was subjected to autoradiography. The arrow
indicates the position of the mature glycosylated form of the CSF-1R
(p165). The kinase activity of CSF-1R from the densitometric analysis
of p165 and the level of CSF-1R from the densitometric analysis of the
immunoblot of the fractions with anti-CSF-1R are shown for each
fraction (bottom panel). (D and E) Immunoblots of the fractions
following the separation of CSF-1-treated (2 min at 37°C) BAC1.2F5
lysate (Lys) (D) and CSF-1R immunoprecipitates (IP) of the fractions
(E) were probed with anti-pTyr or anti-c-Src as indicated.
|
|
The fractionated tyrosine-phosphorylated CSF-1R from CSF-1-stimulated
lysate coimmunoprecipitated with distinct tyrosine-phosphorylated
proteins. The pool of receptor in peak I, although minor, associated
with a significant number of highly tyrosine-phosphorylated proteins
(Fig.
3A), representing a significant proportion of the
tyrosine-phosphorylated
proteins present in this fraction (Fig.
2B).
The extent of tyrosine
phosphorylation of this pool of receptor
following immunoprecipitation
was also consistently high in proportion
to the level of receptor
(Fig.
3A). Tyrosine kinases associating with
the CSF-1R and being
activated during immunoprecipitation with
anti-CSF-1R (see below)
may provide an explanation for the increased
tyrosine phosphorylation.
A low level of this complex was also present
in the untreated
cell lysate fractionation (Fig.
3A, peak I). The
later-eluting
fractions along peak II containing significant levels of
the CSF-1R
were also found to coimmunoprecipitate with fewer but
distinctly
different tyrosine-phosphorylated proteins (Fig.
3A).
It would appear that the CSF-1R-associated complexes identified after
column fractionation must be relatively stable, since
they survive both
column chromatography and subsequent immunoprecipitations.
As further
support for this concept, Fr 17 (peak I) from CSF-1-treated
lysate was
reapplied to a Sephacryl S200 gel filtration column,
which enabled the
fractionation of proteins in the range of 5,000
to 250,000 Da. Almost
all of the tyrosine-phosphorylated proteins
eluted in the void volume
together with the tyrosine-phosphorylated
CSF-1R (data not shown). The
lack of the expected fractionation,
particularly of
low-molecular-weight tyrosine-phosphorylated proteins,
suggests that most of the proteins in this fraction, at least,
were
associated in a multimeric complex(es) (see
Discussion).
Having examined the distribution of tyrosine-phosphorylated proteins in
the anti-CSF-1R immunoprecipitates from the column
chromatography, we
decided to screen these same CSF-1R immunoprecipitates
for signalling
proteins. The Uad pool of CSF-1R did not coimmunoprecipitate
detectable
levels of signalling proteins in either untreated or
CSF-1-stimulated
cells (Fig.
3B), even though it contained a significant
level of these
proteins (Fig.
2C). However, signalling molecules
eluted along the
gradient were found to immunoprecipitate with
anti-CSF-1R (Fig.
3B). STAT3 coimmunoprecipitated with CSF-1R
in peak II (Fr 23 to 26);
this complex is also relatively stable
given that it is maintained
following elution at 250 mM NaCl.
PI-3 kinase was present throughout
the CSF-1R immunoprecipitates
from peak II but also in those from peak
I, a profile correlating
with its detection over a broad range of
fractions (Fig.
2C).
Examination of the CSF-1R immunoprecipitates for
other signalling
proteins revealed that the multimeric complex of
CSF-1R in early-eluting
fractions also contained Shc, Grb2, and Cbl
(data not shown) and
SHP-1 (Fig.
3B). A detectable level of the
multimeric complex
of CSF-1R in peak I was also observed on
fractionation of untreated
lysate. The interactions of CSF-1R with PI-3
kinase and SHP-1
are described below in more
detail.
Kinase activity of CSF-1R forming multimeric complexes.
We
next attempted to establish the correlation between the formation of
multimeric complexes of the CSF-1R and the intrinsic kinase activity of
the CSF-1R in the separate pools. The CSF-1R present in the unadsorbed
fraction (Uad) neither showed CSF-1R kinase activity (Fig. 3C) nor
associated with signalling proteins to form multimeric complexes (Fig.
3A). Almost all of the kinase activity was in the CSF-1R pool present
in the adsorbed fractions, and the degree of kinase activity within
specific adsorbed fractions varied. Peak II showed the maximal level of
kinase activity, which correlates with the fact that these fractions
contain the maximal level of CSF-1R (Fig. 2A and 3C). The major
phosphorylated protein, p165 (Fig. 3C), migrating as a broad band,
corresponds to the mature form of the CSF-1R. The phosphorylated band
at p130 is consistent with the nonglycosylated form of the CSF-1R
(48). In contrast, peak 1 (Fr 17), while containing a
considerable amount of kinase activity in the CSF-1R
immunoprecipitates, showed p165 to be a minor phosphorylated protein in
comparison to other phosphorylated proteins in this fraction, such as
p130, p120, p60, and p45 (Fig. 3C). We suggest that it is more likely
that an associated kinase(s) contributes significantly to the kinase
activity observed in this fraction. Having first established that the
profile of tyrosine-phosphorylated proteins from the separation of
CSF-1-stimulated lysate was consistent with previous fractionations
(Fig. 3D and 2B), we then probed the immunoblot with anti-c-Src (Fig.
3D). A small proportion of tyrosine-phosphorylated c-Src present in
peak I (Fig. 3D) associated with CSF-1R (Fig. 3E), while a large
proportion of c-Src present in the Uad fraction did not
coimmunoprecipitate with the CSF-1R (Fig. 3E).
The SHP-1 multimeric complex with CSF-1R is distinct from the
complex with tyrosine-phosphorylated p140.
The tyrosine
phosphatase SHP-1 has previously been shown to be activated in
macrophages upon CSF-1 stimulation (9, 58). However, stable
interactions between the CSF-1R and SHP-1 have not been demonstrated
(9, 53). We have shown above that fractionation of CSF-1R
pools by chromatography allowed the detection of CSF-1R complexes with
signalling proteins upon CSF-1 stimulation (Fig. 3B), which could not
be demonstrated by immunoprecipitating whole-cell lysate. Probing of
CSF-1R immunoprecipitates with anti-SHP-1 showed that the phosphatase
coimmunoprecipitated in early-eluting CSF-1R pools (Fig. 3B). A
tyrosine-phosphorylated band, p65, comigrated with SHP-1 in the CSF-1R
immunoprecipitates (Fig. 3A). The same complex was also found to
contain PI-3 kinase, Shc, Grb2, and a number of yet-unidentified or
novel tyrosine-phosphorylated proteins.
We further analyzed this complex by immunoprecipitation with anti-SHP-1
antibody. Consistent with observations by others,
anti-SHP-1
immunoprecipitates of total lysate of untreated or
CSF-1-treated
BAC1.2F5 cells showed SHP-1 to be tyrosine phosphorylated
on CSF-1
stimulation but failed to show significant association
of
tyrosine-phosphorylated proteins except p140 (Fig.
4A) (
9).
Immunoprecipitation
of fractions (1 ml) from the separation of
untreated or CSF-1-treated
cell lysate with anti-SHP-1 showed
that tyrosine-phosphorylated protein
p140 coimmunoprecipitated
with SHP-1 in the Uad fraction (Fig.
4B).
Analysis of anti-SHP-1
immunoprecipitates of equal volumes of fractions
(0.3 ml) identified
the Uad fraction as containing the major pool of
SHP-1 which was
not tyrosine phosphorylated to a significant extent.
Longer exposure
showed that tyrosine-phosphorylated p140
coimmunoprecipitated
with SHP-1 (data not shown), as described above.
In contrast,
a low level of SHP-1 in peak I and early-eluting peak II
(Fr 17
to 26) coimmunoprecipitated with CSF-1R and other
tyrosine-phosphorylated
proteins in CSF-1-stimulated cells (Fig.
4B). A
detectable level
of the multimeric complex was also found in
untreated-lysate fractionation
but was limited to peak I (Fig.
4B).
Hence, the two complexes
of SHP-1, namely, SHP-1-CSF-1R and
SHP-1-p140, appear in chromatographically
separate pools, which may
reflect the regulatory role of p140
described recently (
53).
The two immunoreactive bands recognized
by anti-SHP-1 are probably due
to the heterogeneity of SHP-1 caused
by alternate splicing rather than
to cross-reactivity to SHP-2.
SHP-2 migrated with slower mobility than
SHP-1 in total cell lysate
and did not cross-react with either of the
two bands of SHP-1
in anti-SHP-1 immunoprecipitates of the fractions
(data not shown).

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 4.
Specific pools of SHP-1 form multimeric complexes with
CSF-1R and other tyrosine-phosphorylated proteins following CSF-1
stimulation. (A) Total extract of untreated or CSF-1-treated BAC1.2F5
cells was immunoprecipitated with anti-SHP-1, and the immunoblot was
probed with anti-pTyr (4G10). The membrane was then stripped and
reprobed with anti-SHP-1. The arrows indicate the positions of the
tyrosine-phosphorylated proteins p140 and SHP-1. (B) Left panel, the
unadsorbed fraction (U) (1 ml) following the separation of unstimulated
(US) or CSF-1-treated (2 min at 37°C) BAC1.2F5 lysate was
immunoprecipitated with anti-SHP-1. The immunoprecipitates were
resolved by SDS-PAGE and transferred to a nitrocellulose membrane. The
membrane was probed with anti-pTyr (4G10)-HRP. The arrow indicates the
position of the tyrosine-phosphorylated p140. Right panel, equal
volumes (0.3 ml) of the adsorbed and unadsorbed fractions following the
separation of untreated or CSF-1-treated (2 min at 37°C) BAC1.2F5
lysate were immunoprecipitated with anti-SHP-1. The immunoblot of the
samples was initially probed with anti-pTyr (4G10)-HRP and then
stripped and reprobed with anti-CSF-1R and anti-SHP-1. The arrows
indicate the positions of CSF-1R and SHP-1.
|
|
Separation of PI-3 kinase complexes containing different levels of
lipid kinase activity.
PI-3 kinase p85
was observed in
immunoprecipitates of a number of fractions eluted along the NaCl
gradient on fractionation of CSF-1-treated lysate (Fig. 3B). Given the
allosteric regulation of PI-3 kinase by tyrosine-phosphorylated
proteins (42), we decided to analyze the fractions for
enzymatic activity by determining in vitro lipid kinase activity in
immunoprecipitates of PI-3 kinase (Fig.
5A). The main pool of PI-3 kinase present
in the Uad fraction and the less significant pool present in peak I
contained a basal level of activity in untreated and CSF-1-treated cell
lysate fractionations. CSF-1 stimulation resulted in a significant
increase in activity of only selected pools of PI-3 kinase
corresponding to peak II (Fr 29 to 32). The obvious explanation that
these fractions contained higher levels of the protein was eliminated
by probing either the fractions (Fig. 2C) or the PI-3 kinase
immunoprecipitates of the fractions (Fig. 5B) with anti-p85
.

View larger version (51K):
[in this window]
[in a new window]
|
FIG. 5.
PI-3 kinase displays different levels of lipid kinase
activity in the multimeric complexes. (A) Fractions following the
separation of unstimulated (US) or CSF-1-treated (2 min at 37°C)
BAC1.2F5 lysate were immunoprecipitated with anti-PI-3 kinase p85
and the in vitro lipid kinase activity was estimated by thin-layer
chromatography. The arrow indicates the position of PI-3 phosphate.
pKI, peak I. (B) The immunoprecipitates of PI-3 kinase p85 were also
resolved by SDS-PAGE, and the immunoblots were probed with anti-pTyr
(4G10), anti-Cbl, and anti-PI-3 kinase p85 . The positions of
tyrosine-phosphorylated CSF-1R, p95, Cbl, and PI-3 kinase p85 are
indicated. (C) Immunoprecipitates of PI-3 kinase p110 from fractions
17 (peak I) and 23 (peak II) were resolved by SDS-PAGE, and the
proteins were transferred to a nitrocellulose membrane. The membrane
was probed with anti-PI-3 kinase p85 .
|
|
PI-3 kinase immunoprecipitates of the fractions were next analyzed for
associated proteins. The Uad pool, which contained
only a basal level
of lipid kinase activity, failed to coimmunoprecipitate
other
tyrosine-phosphorylated proteins (Fig.
5B). Unlike that
in the Uad
pool, PI-3 kinase p85

in the adsorbed pool was itself
tyrosine
phosphorylated and was found to coimmunoprecipitate with
a significant
number of tyrosine-phosphorylated proteins (Fig.
5B). Despite the
formation of a complex, the PI-3 kinase in peak
I failed to show
significant lipid kinase activity (Fig.
5A).
The multimeric complex of
PI-3 kinase isolated from this pool
containing highly
tyrosine-phosphorylated proteins, including
Cbl, Shc, an unidentified
p95, and CSF-1R (Fig.
5B), corresponds
to that characterized previously
(
24). In contrast, PI-3 kinase
in later-eluting fractions
(Fr 23 to 29 of peak II) contained
maximal levels of PI-3 kinase
activity (Fig.
5A). A similar observation
was made on examination of
lipid kinase activity in anti-pTyr
immunoprecipitates of the adsorbed
fractions (data not shown).
We excluded the possibility that the low
lipid kinase activity
in peak I was due to the absence of the catalytic
subunit p110

.
Coimmunoprecipitation of the regulatory subunit p85

with the
catalytic subunit p110

in Fr 17 and Fr 23, representative
of
peak I and peak II, respectively (Fig.
5C), suggests other reasons
for the modulation in activity. PI-3 kinase in the adsorbed fractions
coimmunoprecipitated with distinctly different tyrosine-phosphorylated
proteins, with CSF-1R being the most prominent tyrosine-phosphorylated
protein present (Fig.
5B). A correlation between the fractions
that
contained the maximal level of tyrosine-phosphorylated CSF-1R
or CSF-1R
kinase activity (Fig.
5B and
3C) and those that exhibited
maximal lipid
kinase activity (Fig.
5A) was observed. Hence, not
all interactions of
PI-3 kinase with tyrosine-phosphorylated proteins
contribute to an
increase in lipid kinase
activity.
Multimeric complexes of CSF-1R contain structural proteins.
The recruitment of CSF-1R and signalling proteins to specific
subcellular sites upon CSF-1 stimulation (1, 5, 8) may
involve interactions with structural protein components. We investigated the distribution of specific cytoskeletal and marker proteins in the fractions following anion-exchange chromatography of
lysate. Clathrin, a structural protein which forms scaffolds in
clathrin-coated pits and coated vesicles (41), appeared in fractions (Fig. 6A) which also contained
the CSF-1R following the fractionation of untreated cell lysate (Uad,
peak I, and peak III in Fig. 2A). CSF-1 stimulation resulted in a
redistribution of anticlathrin immunoreactivity in the adsorbed pool
over a range of NaCl concentrations, with the maximal immunoreactivity
detected in fractions at low NaCl concentrations (peak I). These
fractions overlapped with a part of the pool of tyrosine-phosphorylated CSF-1R (Fig. 2B). Paxillin, a focal adhesion protein, was present in Fr
17 on fractionation of untreated lysate and was found to increase in
amount in the same fraction on CSF-1 stimulation (data not shown).
Dynamin, a GTPase that is involved in the invagination of
clathrin-coated pits to form vesicles (41), displayed a
distribution different from that of clathrin following CSF-1
stimulation. Although a significant pool of dynamin was detected in the
Uad pool in both untreated and CSF-1-treated cells, the observation of
interest was the distribution of the adsorbed pool of dynamin upon
ligand stimulation (Fig. 6A). The maximal immunoreactivity to dynamin in the adsorbed fractions appeared in fractions different from those
containing the maximal level of clathrin but parallel to those
containing the maximal level of CSF-1R (Fig. 2A). Lower levels of
dynamin were detected in early-eluting fractions on longer exposure,
which were previously found to contain clathrin. The meaning of the
recognition of two proteins by antidynamin antibody is not clear at
present but may reflect isoforms of dynamin. Therefore, different
structural proteins eluted with distinct pools of
tyrosine-phosphorylated CSF-1R following CSF-1 stimulation. Furthermore, the presence of dynamin in CSF-1R immunoprecipitates of
fractions from peak II (Fig. 6B) and of clathrin in CSF-1R immunoprecipitates of fractions from peak I (data not shown) on CSF-1
stimulation suggests the formation of multimeric complexes with
specific structural proteins. Although the two proteins recognized by
antidynamin antibody are present in detectable levels in CSF-1R complexes in early-eluting fractions, only the faster-migrating form
was evident in the receptor complexes eluted at higher NaCl concentrations (Fig. 6B). The formation and distribution of the multimeric complexes were dependent on the integrity of the sorting mechanism. Fractionation of lysate from cells pretreated with agents
that affected the polymerization of microtubules, such as nocodazole,
prior to CSF-1 stimulation showed a lack of distribution of
tyrosine-phosphorylated proteins over a range of NaCl concentrations (Fig. 6C). This suggests an absence of formation of the
chromatographically distinct CSF-1R multimeric complexes in
nocodazole-treated cells, consistent with the disruption of the sorting
process (25). Analysis of the fractions from the separation
of control lysate showed a broad elution profile of
tyrosine-phosphorylated proteins, consistent with previous
fractionations (Fig. 2B). Agents that affected the polymerization of
the actin cytoskeleton, such as cytochalasin D, had little effect on
the distribution of tyrosine-phosphorylated proteins, although the
extent of tyrosine phosphorylation of specific proteins in peak I (Fr
17) was diminished (Fig. 6C) relative to that in the corresponding pool
in control CSF-1-stimulated lysate fractionation (Fig. 6C).

View larger version (67K):
[in this window]
[in a new window]
|
FIG. 6.
Structural proteins are distributed in pools containing
specific CSF-1R multimeric complexes. (A) Solubilized lysate of
untreated or CSF-1-treated (2 min at 37°C) BAC1.2F5 cells was applied
to a MonoQ anion-exchange column and eluted with a 0 to 0.4 M NaCl
gradient. Aliquots of protein fractions eluted from the column were
analyzed by Western blotting by probing with anticlathrin or
antidynamin. U, unadsorbed fraction. (B) CSF-1R immunoprecipitates of
the fractions were probed with antidynamin. US, unstimulated. (C)
Lysate of BAC1.2F5 cells treated with nocodazole (40 µg/ml) or
cytochalasin D (2.5 µM) or left untreated prior to stimulation with
CSF-1 for 2 min at 37°C was fractionated on an anion-exchange column,
and the immunoblot of the fractions was probed with anti-pTyr.
|
|
 |
DISCUSSION |
The binding of a ligand to transmembrane receptors initiates the
activation of a number of signal transduction cascades. In order for a
distinct biological signal to be relayed in an organized and
coordinated manner, several regulatory mechanisms exist to ensure the
correct localization and sequence of activation of specific target
proteins (37). The downmodulation of the biological signal
also requires the continuation of the sorting process, perhaps
involving the recruitment and interaction of other proteins (35,
46). The transient interactions between proteins at specific subcellular localization sites require a degree of organization in
modules, which may consist of the selective assembly of large complexes
of proteins (20, 37, 55). Apart from the recruitment of
active enzymes into signalling networks, many modules exist to
facilitate the positioning of substrates close to their activators (20, 55, 60). Adapter, anchoring, and scaffolding proteins play a pivotol role in the specificity of assembly of such signalling networks (37). A well-characterized functioning module, for example, is found in yeast, where a molecular scaffold (Ste 5) physically organizes elements of the mitogen-activated protein kinase
cascade (18). Also, the capacity of B-Raf to activate the
mitogen-activated protein kinase cascade in response to nerve growth
factor was recently shown to correlate with the formation of a stable
association with another scaffolding protein, HSP90 (20).
The discovery of new potential binding partners for CSF-1R by use of
the sensitive yeast two-hybrid technique (7) emphasizes not
only the existence of yet-to-be discovered binding proteins but also
the need to progress to methods which allow for more sensitive
detection of complexes isolated from physiologically relevant cell
populations. A major factor governing the sensitivity of
coimmunoprecipitation studies is the absolute number of receptors expressed on the cell surface (7, 38). CSF-1R, however, is expressed in high numbers (60,000 per cell) on the surface of BAC1.2F5
cells (32), suggesting that a more reasonable explanation is
the low stoichiometry of individual complexes within the cell. Several
factors may contribute to the inability to detect receptor complexes.
The receptor participates in a number of different signalling pathways,
and hence any individual signalling complex may be present in small
amounts. Second, a rapid turnover of signalling protein complexes is
suggested by the presence of stoichiometrically minor
autophosphorylation sites on the receptor (40, 54). The
presence of two different molecules competing for the same site on the
receptor, as recently demonstrated (7), may also further
limit the detection of any one complex.
The yeast two-hybrid technique is limited by the fact that it can
detect only proteins which directly interact with the receptor and will
miss important indirect associations. In addition, this approach can
only demonstrate potential interactions and should be supported with
direct evidence of such associations. We recently showed that a
signalling complex isolated from Triton-solubilized lysates of
macrophages by using anti-PI-3 kinase antibodies was stable enough to
be reisolated following anion-exchange chromatography (24).
This suggested that such a method might provide a general approach to
isolating receptor complexes present in small amounts in the cell. In
this study we have demonstrated chromatographically separate multimeric
complexes of CSF-1R with specific signalling proteins which could not
be detected by coimmunoprecipitation from whole-cell lysates.
Enrichment and fractionation of subpopulations of CSF-1R forming
multimeric complexes.
The CSF-1R solubilized from growth-arrested
macrophages chromatographically resolved into distinct pools which
changed on CSF-1 stimulation of macrophages. In addition, we found that
distinct tyrosine-phosphorylated proteins fractionated with the
separate pools of activated CSF-1R, with a considerable enrichment of
proteins in these fractions (Fig. 2A). Although many of the observed
tyrosine-phosphorylated proteins correspond to known signalling
proteins (such as Cbl [p120], PI-3 kinase [p85], and Shc [p56 and
p46] [Fig. 2A and B]; c-Src [p60] [Fig. 3D]; and Erk 1 and 2 [p44 and p42] [data not shown]), many others remain to be
identified. We are currently using this method as a step to purify
novel proteins involved in CSF-1 signalling. Signalling proteins
previously found to be activated in response to CSF-1 or recruited to
the CSF-1R complex (28, 33, 40, 54, 56, 58) showed distinct
distribution profiles on fractionation of CSF-1-stimulated lysates.
Similar observations have been made on fractionation of nerve growth
factor-stimulated PC12 cell lysate, where coelution of B-Raf with HSP90
was associated with the formation of a functional complex required for
the activation of the mitogen-activated protein kinase pathway
(20). The considerable enrichment of signalling proteins
participating in CSF-1-mediated responses by anion-exchange
chromatography makes this approach a potentially useful tool for analysis.
Our hypothesis for the change in the chromatographic distribution of
the CSF-1R and specific signalling proteins on CSF-1
stimulation is
that it occurs as a consequence of formation of
stable protein
interactions. The observations summarized in Fig.
7 show that a significant proportion of
the CSF-1R (Uad pool)
neither possessed intrinsic kinase activity nor
formed complexes
with other tyrosine-phosphorylated proteins. On the
other hand,
a chromatographically separate CSF-1R pool that eluted at
progressively
higher salt concentrations formed multimeric complexes
with distinct
signalling proteins. This result is significant, since it
demonstrates
that the interactions between the receptor and signalling
proteins
are not simply nonspecific associations; otherwise, a
significant
association of these proteins would be expected to occur
maximally
in the Uad pool under lower-ionic-strength conditions. A
small
pool of CSF-1R eluting at low ionic strength (peak I) was
associated
with Grb2, Shc, PI-3 kinase, SHP-1, c-Src, Cbl, PLC-

2
(data not
shown), and other highly tyrosine-phosphorylated
proteins (Fig.
7). This multimeric complex contained a considerable
amount of
CSF-1R-associated tyrosine kinase activity but a relatively
low
receptor autophosphorylation activity. The receptor-associated
kinase activity is most likely due to kinases associated with
the
CSF-1R, such as c-Src or other members of the Src family such
as Fyn
(
2,
10). An interesting relevant observation was the
presence of paxillin in the early-eluting multimeric complex (data
not
shown), which was present in detectable levels in untreated
cells but
increased on CSF-1 stimulation together with other signalling
proteins.
The complex characterized in peak I is consistent with
recruitment of
signalling proteins to focal complexes (
14,
17)
recently
identified in macrophages which result from cell-to-substratum
contacts
(
1). While this paper was in preparation, a report
published
by Yeung et al. (
59) suggested that many signalling
proteins
recruited to a preexisting cytosolic complex on CSF-1
stimulation are
closely associated with the actin cytoskeleton.
This observation may
relate to the multimeric complex characterized
in peak I of our study,
which was found to interact with a small
pool of CSF-1R. The CSF-1R
multimeric complexes of most interest
were those that appeared
transiently on CSF-1 stimulation in peak
II (Fig.
7). This transient
pool of receptor, representing a significant
proportion of the
activated receptor, formed multimeric complexes
predominantly with Shc,
STAT3, and PI-3 kinase but also with minor
amounts of Grb2 and SHP-1.
We have previously shown that signalling
proteins involved in the
JAK/STAT pathway, STAT3 and TYK2, are
activated by CSF-1R in
macrophages as well as in fibroblasts ectopically
expressing CSF-1R
(
33). We demonstrate in this study that STAT3
in fact forms
a close association with the activated receptor.
These observations are
summarized in Fig.
7.

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 7.
Schematic representation of CSF-1R containing multimeric
complexes fractionated from CSF-1-treated macrophage cell lysate.
CSF-1R resolved into separate pools (Uad, peak I, and peak II)
following the fractionation of CSF-1-treated BAC1.2F5 macrophage cell
lysate on an anion-exchange column. A large pool of CSF-1R (Uad) that
neither showed an appreciable amount of intrinsic tyrosine kinase
activity nor formed multimeric complexes was separated from the
activated pool of CSF-1R that formed chromatographically stable
multimeric complexes. These complexes contained distinct signalling
proteins and tyrosine-phosphorylated (TyrP) proteins. A low level of
CSF-1R present in the adsorbed pool, peak I, formed multimeric
complexes with signalling proteins PI-3 kinase, Grb2, Cbl, c-Src, Shc,
and SHP-1 and a significant number of other highly TyrP proteins. A
transient pool of CSF-1R which resolved as a broad peak (peak II)
formed a range of complexes with specific signalling proteins. The
multimeric complex of CSF-1R in peak II contained predominantly PI-3
kinase, STAT3, and Shc but also minor amounts of SHP-1, c-Src, Grb2,
and other TyrP proteins. A large pool of PI-3 kinase (Uad) with a basal
level of lipid kinase activity did not form multimeric complexes
despite the presence of a significant amount of TyrP proteins. PI-3
kinase present in a number of fractions along the gradient formed a
range of complexes with CSF-1R, but not all complexes contained active
lipid kinase. The early-eluting PI-3 kinase in peak I showed minimal
activity, while PI-3 kinase in peak II contained a significant level of
enzymatic activity. The assembly of chromatographically separate
complexes may reflect the various CSF-1-mediated signalling events
activated in macrophages.
|
|
CSF-1R forms a multimeric complex containing SHP-1.
Analysis
of chromatographically separated lysate from CSF-1-treated macrophages
revealed the existence of a multimeric complex between SHP-1, CSF-1R,
and other proteins which could not be detected by coimmunoprecipitation
from whole-cell lysate. Analysis of the chromatographically enriched
complex also reveals features that are not readily observable by using
the former approach. The tyrosine-phosphorylated SHP-1 present in the
complex with CSF-1R represented a relatively small proportion of the
total pool of SHP-1 and was chromatographically separate from the major
pool of SHP-1 present in the Uad fraction. The latter pool
coimmunoprecipitated with the tyrosine-phosphorylated protein p140,
which was recently found to consist of two transmembrane glycoproteins,
PIR-B/p91A and BIT (53). The CSF-1R contained in the complex
eluting at low ionic strength (peak I) was not tyrosine phosphorylated
to a significant extent compared to other proteins, which appeared to
be strongly tyrosine phosphorylated. This observation could reflect the
intrinsic specificity of SHP-1 for sequences present around the CSF-1R
autophosphorylation sites or, alternatively, that the enzymatic
activity of SHP-1 is constrained by its tight binding within such a
complex. Characterization of this complex may therefore give valuable
information as to how the specificity of SHP-1 for its substrates is
determined, which is of key importance to a better understanding of
CSF-1 signalling, since the motheaten mouse has provided strong
evidence for the importance of SHP-1 in this process (9,
53).
PI-3 kinase displaying different specific enzyme activities in
different multimeric complexes.
We have previously shown that PI-3
kinase is a major binding partner for the CSF-1R, being the only
protein identifiable as specifically binding to the receptor in
anti-CSF-1R immunoprecipitates prepared from
[35S]methionine-labelled cells (24).
Consistent with this, approximately 85% of the receptor in BAC1.2F5
cells can be isolated in anti-PI-3 kinase immunoprecipitates
(22a). In the present study, we observed that PI-3 kinase
was widely distributed throughout the column profile when lysates
prepared from activated macrophages were analyzed and that PI-3 kinase
in these pools was associated with the CSF-1R. The large number of
chromatographically distinct complexes between the receptor and PI-3
kinase may reflect the participation of PI-3 kinase in multiple
CSF-1-mediated events. We have previously shown that PI-3 kinase is
involved in the CSF-1-dependent activation of p70s6 kinase
(16) and in pathways of CSF-1 degradation in some
populations of macrophages (23). When the PI-3 kinase
activities in the various pools were measured, we found that not all of
the complexes containing tyrosine-phosphorylated PI-3 kinase and
receptor were enzymatically active (Fig. 7). Most of the PI-3 kinase
activity was found in complexes that contained predominantly
tyrosine-phosphorylated CSF-1R (peak II). In contrast, the complex of
tyrosine-phosphorylated PI-3 kinase, CSF-1R, Cbl, Grb2, Shc, SHP-1, and
other tyrosine-phosphorylated proteins (24) did not have
lipid kinase activity significantly above the basal level (Fig. 7).
Hence, column chromatography has enabled the separation of distinct
PI-3 kinase multimeric complexes participating in CSF-1-mediated
events. It is not yet clear whether the PI-3 kinase present in either
of the complexes binds directly to the receptor. However, what is known
so far about the regulation of PI-3 kinase suggests that the active
pool is the result of either direct interaction of the SH2 domains of
the p85
regulatory subunit with phosphorylated tyrosine 721 of the
CSF-1R (40) or occupation of both SH2 domains by more than
one protein (42). We are currently investigating these alternatives.
Significance of the chromatographically distinct multimeric
complexes of CSF-1R.
Our hypothesis is that the chromatographic
behavior of the solubilized CSF-1R and signalling proteins is related
to the formation of stable interactions with distinct proteins involved
in different intracellular signalling events. These interactions would
include scaffolding and structural proteins. In this regard, it is
interesting that clathrin, dynamin, and paxillin cochromatograph with
distinct pools of the CSF-1R upon CSF-1 stimulation but, more
significantly, that some were found to associate with the CSF-1R pools.
A small pool of CSF-1R associating with paxillin formed multimeric
complexes consistent with focal complexes, as discussed above.
Signalling proteins Shc, Cbl, SHP-1, PI-3 kinase, and Grb2 were
identified in this complex with a significant number of other highly
tyrosine-phosphorylated proteins, reflecting the extent of kinase
activity in the complex. We did not detect immunoreactivity to anti-Fak
in this peak. The recent report of the activation of the related
adhesion focal tyrosine kinase by CSF-1 in monocyte-macrophages
(17) may provide an explanation for the lack of detection of
Fak in our study. A large proportion of the activated CSF-1R,
representing a chromatographically separate but transient pool, formed
multimeric complexes with distinctly different tyrosine-phosphorylated
proteins that included signalling proteins STAT3, Shc, PI-3 kinase, and
minor levels of SHP-1 and Grb2. This transient pool of activated CSF-1R
coimmunoprecipitated with dynamin. Although dynamin guanosine
triphosphatases have been implicated in scission of clathrin-coated
vesicles from the plasma membrane during endocytosis (41),
recent studies also suggest that other isoforms of dynamin participate
in the formation of distinct transport vesicles from the trans-Golgi
network (22). The presence of the active pool of PI-3 kinase
in the complex containing CSF-1R and dynamin in our study is
particularly interesting given the role of PI-3 kinase in
PDGFR-mediated endocytosis (21, 46), where endosomes
containing PI-3 kinase were found to be associated with microtubule
network (25). Other signalling proteins have also been
implicated in receptor-mediated endocytosis (57). The
formation of the distinct multimeric complexes of the CSF-1R is
dependent on the integrity of the sorting mechanism of which the
microtubular network forms an integral part. There is a considerable amount of literature on the localization and recruitment of specific signalling proteins into structures such as postendocytic vesicles (11, 49, 50), focal complexes (1, 17), and
caveoli (4, 29). Marker proteins for caveoli in macrophages
have not been identified, but it would be of considerable interest if
the complexes described in this study could be identified with those
present in such organelles. We have attempted to address the importance
of studying specific pools of signalling proteins and their regulation
in CSF-1-mediated signalling through interaction with other proteins,
including scaffolding proteins. Although we have characterized pools
with respect to CSF-1R, PI-3 kinase, and SHP-1 in some detail,
understanding of the nature of the specific interactions that
distinguish the pools requires further study.
 |
ACKNOWLEDGMENTS |
We are grateful to Heung-Chin Cheng for helpful comments on the
manuscript. We also thank Graeme Guy, Ulrike Novak, and Peter Vadiveloo
for helpful discussions.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Medicine, University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria 3050, Australia. Phone: (61 3) 93445478. Fax: (61 3) 93471863. E-mail: v.kanagasundaram{at}medicine.unimelb.edu.au.
Present address: AIDS Pathogenesis Research Unit, Macfarlane Burnet
Centre for Medical Research, Fairfield, Victoria 3078, Australia.
 |
REFERENCES |
| 1.
|
Allen, W. E.,
G. E. Jones,
J. W. Pollard, and A. J. Ridley.
1997.
Rho, Rac and Cdc42 regulate actin organization and cell adhesion in macrophages.
J. Cell Sci.
110:707-720[Abstract].
|
| 2.
|
Alonso, G.,
M. Koegl,
N. Mazurenko, and S. A. Courtneidge.
1995.
Sequence requirements for binding of Src family tyrosine kinases to activated growth factor receptors.
J. Biol. Chem.
270:9840-9848[Abstract/Free Full Text].
|
| 3.
|
Baccarini, M.,
D. M. Sabatini,
H. App,
U. R. Rapp, and E. R. Stanley.
1990.
Colony stimulating factor-1 (CSF-1) stimulates temperature dependent phosphorylation and activation of the Raf-1 proto-oncogene product.
EMBO J.
9:3649-3657[Medline].
|
| 4.
|
Bohuslav, J.,
V. Horejsi,
C. Hansmann,
J. Stockl,
U. H. Weidle,
O. Majdic,
I. Bartke,
W. Knapp, and H. Stockinger.
1995.
Urokinase plasminogen activator receptor, 2-integrins, and Src-kinases within a single receptor complex of human monocytes.
J. Exp. Med.
181:1381-1390[Abstract/Free Full Text].
|
| 5.
|
Boocock, C. A.,
G. E. Jones,
E. R. Stanley, and J. W. Pollard.
1989.
Colony-stimulating factor-1 induces rapid behavioural responses in the mouse macrophage cell line, BAC1.2F5.
J. Cell Sci.
93:447-456[Abstract/Free Full Text].
|
| 6.
|
Bourette, R. P.,
G. M. Myles,
K. Carlberg,
A. R. Chen, and L. R. Rohrschneider.
1995.
Uncoupling of the proliferation and differentiation signals mediated by the murine macrophage colony-stimulating factor receptor expressed in myeloid FDC-P1 cells.
Cell Growth Differ.
6:631-645[Abstract].
|
| 7.
|
Bourette, R. P.,
G. M. Myles,
J.-L. Choi, and L. R. Rohrschneider.
1997.
Sequential activation of phosphatidylinositol 3-kinase and phospholipase C- 2 by the M-CSF receptor is necessary for differentiation signaling.
EMBO J.
16:5880-5893[Medline].
|
| 8.
|
Chen, B. D.-M.,
C. Kuhn III, and H.-S. Lin.
1984.
Receptor-mediated binding and internalization of colony-stimulating factor (CSF-1) by mouse peritoneal exudate macrophages.
J. Cell Sci.
70:147-166[Abstract].
|
| 9.
|
Chen, H. E.,
S. Chang,
T. Trub, and B. G. Neel.
1996.
Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1.
Mol. Cell. Biol.
16:3685-3697[Abstract].
|
| 10.
|
Courneidge, S. A.,
R. Dhand,
D. Pilat,
G. M. Twamley,
M. D. Waterfield, and M. F. Roussel.
1993.
Activation of Src family kinases by colony stimulating factor-1, and their association with its receptor.
EMBO J.
12:943-950[Medline].
|
| 11.
|
Di Guglielmo, G. M.,
P. C. Baass,
W. J. Ou,
B. I. Posner, and J. J. M. Bergeron.
1994.
Compartmentalization of Shc, Grb2 and mSos, and hyperphosphorylation of Raf-1 by EGF but not insulin in liver parenchyma.
EMBO J.
13:4269-4277[Medline].
|
| 12.
|
Downing, J. R.,
B. L. Margolis,
A. Zilberstein,
R. A. Ashmun,
A. Ullrich,
C. J. Sherr, and J. Schlessinger.
1989.
Phospholipase C-gamma, a substrate for PDGF receptor kinase, is not phosphorylated on tyrosine during the mitogenic response to CSF-1.
EMBO J.
8:3345-3350[Medline].
|
| 13.
|
Downing, J. R.,
C. W. Rettenmier, and C. J. Sherr.
1988.
Ligand-induced tyrosine kinase activity of colony-stimulating factor-1 receptor in murine macrophage cell line.
Mol. Cell. Biol.
8:1795-1799[Abstract/Free Full Text].
|
| 14.
|
Ganju, R. K.,
W. C. Hatch,
H. Avraham,
M. A. Ona,
B. Druker,
S. Avraham, and J. E. Groopman.
1997.
RAFTK, a novel member of the focal adhesion kinase family, is phosphorylated and associates with signaling molecules upon activation of mature T lymphocytes.
J. Exp. Med.
185:1055-1063[Abstract/Free Full Text].
|
| 15.
|
Guilbert, L. J., and E. R. Stanley.
1986.
The interaction of 125I-colony-stimulating factor-1 with bone marrow-derived macrophages.
J. Biol. Chem.
261:4024-4032[Abstract/Free Full Text].
|
| 16.
|
Hamilton, J. A.,
R. Byrne,
G. Whitty,
P. K. Vadiveloo,
N. Marmy,
R. B. Pearson,
E. Christy, and A. Jaworowski.
1998.
Effects of wortmannin and rapamycin on CSF-1-mediated responses in macrophages.
Int. J. Biochem. Cell Biol.
30:271-283[Medline].
|
| 17.
|
Hatch, W. C.,
R. K. Ganju,
D. Hiregowdara,
S. Avraham, and J. E. Groopman.
1998.
The related adhesion focal tyrosine kinase (RAFTK) is tyrosine phosphorylated and participates in colony-stimulating factor-1/macrophage colony-stimulating factor signaling in monocyte-macrophages.
Blood
91:3967-3973[Abstract/Free Full Text].
|
| 18.
|
Herskowitz, I.
1995.
MAP kinase pathways in yeast: for mating and more.
Cell
80:187-197[Medline].
|
| 19.
|
Husson, H.,
B. Mograbi,
H. Schmid-Antomarchi,
S. Fischer, and B. Rossi.
1997.
CSF-1 stimulation induces the formation of a multiprotein complex including CSF-1 receptor, c-Cbl, PI 3-kinase, Crk-II and Grb2.
Oncogene
14:2331-2338[Medline].
|
| 20.
|
Jaiswal, R. K.,
E. Weissinger,
W. Kolch, and G. E. Landreth.
1996.
Nerve growth factor-mediated activation of the mitogen-activated protein (MAP) kinase cascade involves a signaling complex containing B-Raf and HSP90.
J. Biol. Chem.
271:23626-23629[Abstract/Free Full Text].
|
| 21.
|
Joly, M.,
A. Kazlauskas, and S. Corvera.
1995.
Phosphatidylinositol 3-kinase activity is required at a postendocytic step in platelet-derived growth factor receptor trafficking.
J. Biol. Chem.
270:13225-13230[Abstract/Free Full Text].
|
| 22.
|
Jones, S. M.,
K. E. Howell,
J. R. Henley,
H. Cao, and M. A. McNiven.
1998.
Role of dynamin in the formation of transport vesicles from the trans-Golgi network.
Science
279:573-577[Abstract/Free Full Text].
|
| 22a.
| Kanagasundaram, V. Unpublished data.
|
| 23.
|
Kanagasundaram, V.,
E. Christy,
J. A. Hamilton, and A. Jaworowski.
1998.
Different pathways of colony stimulating factor-1 degradation in macrophage populations revealed by wortmannin sensitivity.
Biochem. J.
330:197-202.
|
| 24.
|
Kanagasundaram, V.,
A. Jaworowski, and J. A. Hamilton.
1996.
Association between phosphatidylinositol-3 kinase, Cbl and other tyrosine phosphorylated proteins in CSF-1 stimulated macrophages.
Biochem. J.
320:68-77.
|
| 25.
|
Kapeller, R.,
R. Chakrabarti,
L. Cantley,
F. Fay, and S. Corvera.
1993.
Internalization of activated platelet-derived growth factor receptor-phosphatidylinositol-3' kinase complexes: potential interactions with microtubule cytoskeleton.
Mol. Cell. Biol.
13:6052-6063[Abstract/Free Full Text].
|
| 26.
|
Kaplan, D. R.,
M. Whitman,
B. Schaffhausen,
D. C. Pallas,
M. White,
L. Cantley, and T. M. Roberts.
1987.
Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein phosphotidylinositol kinase activity.
Cell
50:1021-1029[Medline].
|
| 27.
|
Li, W., and E. R. Stanley.
1991.
Role of dimerization and modification of the CSF-1 receptor in its activation and internalization during the CSF-1 response.
EMBO J.
10:277-288[Medline].
|
| 28.
|
Lioubin, M. N.,
G. M. Myles,
K. Carlberg,
D. Bowtell, and L. R. Rohrschneider.
1994.
SHC, GRB2, SOS1, and a 150-kilodalton tyrosine-phosphorylated protein form complexes with Fms in hematopoietic cells.
Mol. Cell. Biol.
14:5682-5691[Abstract/Free Full Text].
|
| 29.
|
Liu, P.,
Y. Ying,
Y.-G. Ko, and R. G. W. Anderson.
1996.
Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae.
J. Biol. Chem.
271:10299-10303[Abstract/Free Full Text].
|
| 30.
|
Lowenstein, E. J.,
R. J. Daly,
A. G. Batzer,
W. Li,
B. Margolis,
R. Lammers,
A. Ullrich,
E. Y. Skolnik,
D. Bar Sagi, and J. Schlessinger.
1992.
The SH2 and SH3 domain-containing protein Grb2 links receptor tyrosine kinases to ras signaling.
Cell
70:431-442[Medline].
|
| 31.
|
Manger, R.,
L. Najita,
E. J. Nichols,
S. Hakomori, and L. Rohrschneider.
1984.
Cell surface expression of the McDonough strain of feline sarcoma virus fms gene product (gp140fms).
Cell
39:327-337[Medline].
|
| 32.
|
Morgan, C.,
J. W. Pollard, and E. R. Stanley.
1987.
Isolation and characterization of a cloned growth factor dependent macrophage cell line, BAC1.2F5.
J. Cell. Physiol.
130:420-427[Medline].
|
| 33.
|
Novak, U.,
A. G. Harpur,
L. Paradiso,
V. Kanagasundaram,
A. Jaworowski,
A. F. Wilks, and J. A. Hamilton.
1995.
CSF-1 induced Stat1 and Stat3 activation is accompanied by phosphorylation of Tyk2 in macrophage and Tyk2 and Jak1 in fibroblasts.
Blood
86:2948-2956[Abstract/Free Full Text].
|
| 34.
|
Novak, U.,
E. Nice,
J. A. Hamilton, and L. Paradiso.
1996.
Requirement for Y706 of the murine (or Y708 of the human) CSF-1 receptor for Stat1 activation in response to CSF-1.
Oncogene
13:2607-2613[Medline].
|
| 35.
|
Ohno, H.,
J. Stewart,
M.-C. Fournier,
H. Bosshart,
I. Rhee,
S. Miyatake,
T. Saito,
A. Gallusser,
T. Kirchhausen, and J. S. Bonifacino.
1995.
Interaction of tyrosine-based sorting signals with clathrin-associated proteins.
Science
269:1872-1875[Abstract/Free Full Text].
|
| 36.
|
Ota, Y., and L. E. Samelson.
1997.
The product of the proto-oncogene c-cbl: a negative regulator of the Syk tyrosine kinase.
Science
276:418-420[Abstract/Free Full Text].
|
| 37.
|
Pawson, T., and J. D. Scott.
1997.
Signaling through scaffold, anchoring, and adaptor proteins.
Science
278:2075-2080[Abstract/Free Full Text].
|
| 38.
|
Ponzetto, C.,
A. Bardelli,
Z. Zhen,
F. Maina,
P. dalla Zonca,
S. Giordano,
A. Graziani,
G. Panayotou, and P. M. Comoglio.
1994.
A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor family.
Cell
77:261-271[Medline].
|
| 39.
|
Reedijk, M.,
X. Liu, and T. Pawson.
1990.
Interactions of phosphatidylinositol kinase, GTPase-activating protein (GAP), and GAP-associated proteins with the colony-stimulating factor 1 receptor.
Mol. Cell. Biol.
10:5601-5608[Abstract/Free Full Text].
|
| 40.
|
Reedijk, M.,
X. Liu,
P. van der Geer,
K. Letwin,
M. D. Waterfield,
T. Hunter, and T. Pawson.
1992.
Tyr721 regulates specific binding of the CSF-1 receptor kinase insert to PI 3'-kinase SH2 domains: a model for SH2-mediated receptor target interactions.
EMBO J.
11:1365-1372[Medline].
|
| 41.
|
Robinson, M. S.
1994.
The role of clathrin, adaptors and dynamin in endocytosis.
Curr. Opin. Cell Biol.
6:538-544[Medline].
|
| 42.
|
Rordorf-Nikolic, T.,
D. J. van Horn,
D. Chen,
M. F. White, and J. M. Backer.
1995.
Regulation of phosphatidylinositol 3'-kinase by tyrosyl phosphoproteins.
J. Biol. Chem.
270:3662-3666[Abstract/Free Full Text].
|
| 43.
|
Rosnet, O., and D. Birnbaum.
1993.
Hematopoietic receptors of class III receptor-type tyrosine kinases.
Crit. Rev. Oncogen.
4:595-613[Medline].
|
| 44.
|
Roussel, M. F.,
T. J. Dull,
C. W. Rettenmier,
P. Ralph,
A. Ullrich, and C. J. Sherr.
1987.
Transforming potential of the c-fms proto-oncogene (CSF-1 receptor).
Nature
325:549-552[Medline].
|
| 45.
|
Roussel, M. F.,
S. A. Shurtleff,
J. R. Downing, and C. J. Sherr.
1990.
A point mutation at tyrosine 809 in the human colony-stimulating factor 1 receptor impairs mitogenesis without abrogating tyrosine kinase activity, association with phosphatidylinositol 3-kinase, or induction of fos and junB genes.
Proc. Natl. Acad. Sci. USA
87:6738-6742[Abstract/Free Full Text].
|
| 46.
|
Scaife, R.,
I. Gout,
M. D. Waterfield, and R. L. Margolis.
1994.
Growth factor-induced binding of dynamin to signal transduction proteins involves sorting to distinct and separate proline-rich dynamin sequences.
EMBO J.
13:2574-2582[Medline].
|
| 47.
|
Sengupta, A.,
W.-K. Liu,
Y. G. Yeung,
D. C. Y. Yeung,
A. R. Frackelton, Jr., and E. R. Stanley.
1988.
Identification and subcellular localization of proteins that are rapidly phosphorylated in tyrosine in response to colony-stimulating factor-1.
Proc. Natl. Acad. Sci. USA
85:8062-8066[Abstract/Free Full Text].
|
| 48.
|
Sherr, C. J.,
C. W. Rettenmier,
R. Sacca,
M. F. Roussel,
A. T. Look, and E. R. Stanley.
1985.
The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1.
Cell
41:665-676[Medline].
|
| 49.
|
Sorkin, A.,
A. Eriksson,
C.-H. Heldin,
B. Westermark, and L. Claesson-Welsh.
1993.
Pool of ligand-bound platelet-derived growth factor -receptors remain activated and tyrosine phosphorylated after internalization.
J. Cell. Physiol.
156:373-382[Medline].
|
| 50.
|
Sorkin, A., and C. M. Waters.
1993.
Endocytosis of growth factor receptors.
Bioessays
15:375-382[Medline].
|
| 51.
|
Stanley, E. R.,
L. J. Guilbert,
R. J. Tushinski, and S. H. Bartelmez.
1983.
CSF-1-A mononuclear phagocyte lineage-specific hematopoietic growth factor.
J. Cell. Biochem.
21:151-159[Medline].
|
| 52.
|
Tapley, P.,
A. Kazlauskas,
J. A. Cooper, and L. R. Rohrschneider.
1990.
Macrophage colony-stimulating factor-induced tyrosine phosphorylation of c-fms proteins expressed in FDC-P1 and BALB/c-3T3 cells.
Mol. Cell. Biol.
10:2528-2538[Abstract/Free Full Text].
|
| 53.
|
Timms, J. F.,
K. Carlberg,
H. Gu,
H. Chen,
S. Kamatkar,
M. J. S. Nadler,
L. R. Rohrschneider, and B. G. Neel.
1998.
Identification of major binding proteins and substrates for the SH2-containing protein tyrosine phosphatase SHP-1 in macrophages.
Mol. Cell. Biol.
18:3838-3850[Abstract/Free Full Text].
|
| 54.
|
van der Geer, P., and T. Hunter.
1993.
Mutation of Tyr697, a GRB2-binding site, and Tyr721, a PI 3-kinase binding site, abrogates signal transduction by the murine CSF-1 receptor expressed in Rat-2 fibroblasts.
EMBO J.
12:5161-5172[Medline].
|
| 55.
|
van Hoek, M.,
C. S. Allen, and S. J. Parsons.
1997.
Phosphotyrosine phosphatase activity associated with c-Src in large multimeric complexes isolated from adrenal medullary chromaffin cells.
Biochem. J.
326:271-277.
|
| 56.
|
Wang, Y.,
Y.-G. Yeung,
W. Y. Langdon, and E. R. Stanley.
1996.
c-Cbl is transiently tyrosine-phosphorylated, ubiquitinated, and membrane-targeted following CSF-1 stimulation of macrophages.
J. Biol. Chem.
271:17-20[Abstract/Free Full Text].
|
| 57.
|
Wang, Z., and M. F. Moran.
1996.
Requirement for the adaptor protein Grb2 in EGF receptor endocytosis.
Science
272:1935-1938[Abstract].
|
| 58.
|
Yeung, Y. G.,
K. L. Berg,
F. J. Pixley,
R. H. Angeletti, and E. R. Stanley.
1992.
Protein tyrosine phosphatase-1C is rapidly phosphorylated in tyrosine in macrophages in response to colony stimulating factor-1.
J. Biol. Chem.
267:23447-23450[Abstract/Free Full Text].
|
| 59.
|
Yeung, Y.-G.,
Y. Wang,
D. B. Einstein,
P. S. W. Lee, and E. R. Stanley.
1998.
Colony-stimulating factor-1 stimulates the formation of multimeric cytosolic complexes of signaling proteins and cytoskeletal components in macrophages.
J. Biol. Chem.
273:17128-17137[Abstract/Free Full Text].
|
| 60.
|
Zanke, B. W.,
E. A. Rubie,
E. Winnett,
J. Chan,
S. Randall,
M. Parsons,
K. Boudreau,
M. McInnis,
M. Yan,
D. J. Templeton, and J. R. Woodgett.
1996.
Mammalian mitogen-activated protein kinase pathways are regulated through formation of specific kinase-activator complexes.
J. Biol. Chem.
271:29876-29881[Abstract/Free Full Text].
|
| 61.
|
Zhang, Z. Y.,
J. P. Davis, and R. L. Van Etten.
1992.
Covalent modification and active-site directed inactivation of a low molecular weight phosphotyrosyl protein phosphatase.
Biochemistry
31:1701-1711[Medline].
|
Molecular and Cellular Biology, June 1999, p. 4079-4092, Vol. 19, No. 6
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Liu, Y., Kruhlak, M. J., Hao, J.-J., Shaw, S.
(2007). Rapid T cell receptor-mediated SHP-1 S591 phosphorylation regulates SHP-1 cellular localization and phosphatase activity. J. Leukoc. Biol.
82: 742-751
[Abstract]
[Full Text]
-
Yeung, Y.-G., Stanley, E. R.
(2003). Proteomic Approaches to the Analysis of Early Events in Colony-stimulating Factor-1 Signal Transduction. Mol. Cell. Proteomics
2: 1143-1155
[Abstract]
[Full Text]
-
Bourgin, C., Bourette, R. P., Arnaud, S., Liu, Y., Rohrschneider, L. R., Mouchiroud, G.
(2002). Induced Expression and Association of the Mona/Gads Adapter and Gab3 Scaffolding Protein during Monocyte/Macrophage Differentiation. Mol. Cell. Biol.
22: 3744-3756
[Abstract]
[Full Text]
-
Tilbrook, P. A., Palmer, G. A., Bittorf, T., McCarthy, D. J., Wright, M. J., Sarna, M. K., Linnekin, D., Cull, V. S., Williams, J. H., Ingley, E., Schneider-Mergener, J., Krystal, G., Klinken, S. P.
(2001). Maturation of Erythroid Cells and Erythroleukemia Development Are Affected by the Kinase Activity of Lyn. Cancer Res.
61: 2453-2458
[Abstract]
[Full Text]
-
Lai, C.-C., Henningson, C., DiMaio, D.
(2000). Bovine Papillomavirus E5 Protein Induces the Formation of Signal Transduction Complexes Containing Dimeric Activated Platelet-derived Growth Factor beta Receptor and Associated Signaling Proteins. J. Biol. Chem.
275: 9832-9840
[Abstract]
[Full Text]
-
Murray, J, Wilson, L, Kellie, S
(2000). Phosphatidylinositol-3' kinase-dependent vesicle formation in macrophages in response to macrophage colony stimulating factor. J. Cell Sci.
113: 337-348
[Abstract]